Similar companies
Income Statement (NONE)
| Q3 '24 | QoQ | |
|---|---|---|
| Revenue | 1.75B | 0.1% |
| Gross Profit | 596M | 4.9% |
| Cost of Revenue | 1.16B | 2.3% |
| Operating expense | 382M | 7% |
| Net Income | 113M | 1.7% |
| EBITDA | 362M | 0.3% |
Balance Sheet (NONE)
| Q3 '24 | QoQ | |
|---|---|---|
| Total Assets | 11.6B | 3.2% |
| Total Liabilities | 5.42B | 3.9% |
| Total Equity | 5.87B | 2.2% |
| Shares Outstanding | 1.29B | 0% |
Cash Flow (NONE)
| Q3 '24 | QoQ | |
|---|---|---|
| Cash from operations | 408M | 29.1% |
| Cash from financing | -107M | 50.5% |
EPS
Financial Highlights for ICL Israel Chemicals in Q3 '24
ICL Israel Chemicals reported a revenue of 1.75B, which is a 0.1% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 596M, marking a 4.9% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 1.16B, a -2.3% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 382M, showing a 7% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 113M, showing a -1.7% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 362M, showing a -0.3% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
ICL Israel Chemicals faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. Higher operating expenses might indicate increased investments or potential inefficiencies. A decline in EBITDA signals potential operational challenges or increased costs.
